340b

Federal Health Policy Update for January 15

The following is the latest health policy news from the federal government for January 9-15.  Some of the language used below is taken directly from government documents. The White House The White House has unveiled “The Great Healthcare Plan,” which it describes as “… a broad healthcare initiative that will slash prescription drug prices, reduce insurance premiums, hold big insurance companies accountable, and maximize price transparency in the American healthcare system.”  The major components of the plan, and the key steps for each, are: lower drug prices slash prescription drug prices allow more over-the-counter medicines lower insurance premiums send the [...]

340B Pilot in Limbo After Court Acts – Twice

The future of the Department of Health and Human Services’ 340B Rebate Model Pilot Program is in jeopardy after two setbacks in federal court. A federal court issued a preliminary injunction preventing HHS from implementing the limited model, which was to test replacing the discounts that pharmaceutical companies provide to eligible providers participating in the section 340B prescription drug program when they purchase prescription drugs with post-purchase rebates for products they have already purchased. In issuing its injunction, the court wrote that … the Administrative Procedure Act’s (APA) arbitrary and capricious standard imposes vanishingly minimal requirements that a federal agency [...]

2026-01-13T16:50:39-05:00January 15, 2026|340b|

Federal Health Policy Update for January 8

The following is the latest health policy news from the federal government for December 29 to January 8.  Some of the language used below is taken directly from government documents. Congress Congress returned from winter recess facing a full policy agenda and health care issues remain prominent.  Following the expiration of the Affordable Care Act’s enhanced premium tax credits, the House is expected to vote on a three-year clean extension brought by a discharge petition from Democratic House Leader Hakeem Jefferies (D-NY).  The Senate is unlikely to advance the measure but a bipartisan group of senators is developing an alternative:  [...]

Federal Health Policy Update for December 4

The following is the latest health policy news from the federal government for November 21 through December 4.  Some of the language used below is taken directly from government documents. Congress Congress is back in session to discuss the Affordable Care Act tax credits set to end on December 31and other extenders that will expire on January 30, 2026 along with the latest continuing resolution (CR). Members continue to negotiate potential solutions to the expiring enhanced Affordable Care Act premium subsidies but there is no consensus on whether or how to address the expiring benefit.  Senate Majority Leader Thune (R-SD) [...]

Federal Health Policy Update for November 6

The following is the latest health policy news from the federal government for October 31 – November 6.  Some of the language used below is taken directly from government documents. Please note that most HHS and other health care-related agencies have indicated that they will not be announcing new policies, publishing proposed regulations, or updating their web sites during the current federal government shutdown; some are engaging in limited exceptions. Congress and the Shutdown Senate Majority Leader John Thune (R-SD) today told his caucus that he plans to bring the House-passed CR to yet another vote in the Senate on [...]

HHS Sets 340B Rebate Model

The Department of Health and Human Services’ Health Resources and Services Administration has approved eight plans from pharmaceutical companies to participate in its 340B Rebate Model Pilot Program. Currently, eligible 340B providers receive discounts when they purchase covered drugs but under the rebate model, covered entities continue to make purchases through their 340B wholesaler and will seek rebates from the pharmaceutical companies for the ten affected drugs dispensed to 340B-eligible patients after a purchase is made. Providers argue that the new approach creates a new, significant administrative burden for them and could affect their cash flow while pharmaceutical companies maintain [...]

2025-11-05T12:45:32-05:00November 6, 2025|340b|

Federal Health Policy Update for October 30

The following is the latest health policy news from the federal government for October 24-30.  Some of the language used below is taken directly from government documents. Please note that most HHS and other health care-related agencies have indicated that they will not be announcing new policies, publishing proposed regulations, or updating their web sites during the current federal government shutdown. Congress and the Shutdown The federal government remains shut down and the Senate expects to leave Washington today without another vote on the House-passed continuing resolution (CR), ensuring that the shutdown will continue into next week.  Republican leaders believe [...]

Senate Committee Looks at 340B

Last week the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the 340B Drug Pricing Program, which provides discounted prescription drugs to eligible health care providers, known as "covered entities," to help them serve low-income and uninsured patients. In recent years the 340B program has become more controversial as it has grown and as pharmaceutical companies object more strenuously to the discounts they are required to provide to participating providers.  In addition, some critics charge that the savings providers gain from 340B discounts are not consistently reinvested in care for low-income and uninsured patients while those [...]

2025-10-28T15:50:27-04:00October 29, 2025|340b, Congress|

Senate Committee Looks at 340B

Last week the Senate Committee on Health, Education, Labor and Pensions held a hearing on the 340B Drug Pricing Program to discuss its growth and impact on patients. Among other subjects, the committee reviewed the importance of the 340B program; the pharmaceutical manufacturers’ rebate program that begins in January; potential transparency reforms; ensuring that 340B entities do not receive duplicate drug discounts; revising the definition of a patient for a covered entity; and reforms involving the use of contract pharmacies. Representatives from the Government Accountability Office, Congressional Budget Office (CBO), UCLA served on the hearing’s witness panel. Go here to find [...]

2025-10-23T14:02:22-04:00October 27, 2025|340b|

Federal Health Policy Update for October 23

The following is the latest health policy news from the federal government for October 17 - 23.  Some of the language used below is taken directly from government documents. Please note that most HHS and other health care-related agencies have indicated that they will not be announcing new policies, publishing proposed regulations, or updating their web sites during the current federal government shutdown. Congress and the Shutdown The Senate postponed its 13th vote on the House-passed continuing resolution (CR), scheduled for today; without bipartisan negotiations on Affordable Care Act enhanced premium subsidies, the measure – whenever the next vote is [...]

Go to Top